2020
Efficacy and safety of intravascular lithotripsy for the treatment of peripheral arterial disease: An individual patient‐level pooled data analysis
Madhavan MV, Shahim B, Mena‐Hurtado C, Garcia L, Crowley A, Parikh SA. Efficacy and safety of intravascular lithotripsy for the treatment of peripheral arterial disease: An individual patient‐level pooled data analysis. Catheterization And Cardiovascular Interventions 2020, 95: 959-968. PMID: 31957955, PMCID: PMC7187419, DOI: 10.1002/ccd.28729.Peer-Reviewed Original ResearchConceptsIndividual patient-level dataPeripheral arterial diseaseUse of IVLIntravascular lithotripsyArterial diseaseProspective studyTreatment of PADSafety of IVLPeripheral arterial calcificationPeripheral artery calcificationPeripheral intravascular lithotripsyProcedural angiographic complicationsFlow-limiting dissectionIndependent core laboratoryTreatment of patientsPercent diameter stenosisLong-term patencyPatient-level dataAngiographic complicationsAcute successEfficacy endpointEndovascular revascularizationSafety endpointArtery calcificationDistal embolization
2015
Local delivery of paclitaxel in the treatment of peripheral arterial disease
Ng VG, Mena C, Pietras C, Lansky AJ. Local delivery of paclitaxel in the treatment of peripheral arterial disease. European Journal Of Clinical Investigation 2015, 45: 333-345. PMID: 25615282, DOI: 10.1111/eci.12407.Peer-Reviewed Original ResearchConceptsPeripheral artery diseaseEndovascular revascularizationArtery diseaseLocal deliveryClinical studiesLocal drug deliveryPeripheral arterial diseasePeripheral vascular diseasePrimary patency rateSystemic adverse effectsUse of paclitaxelLong-term efficacyDrug-Eluting BalloonDrug-eluting stentsTerms of efficacyBrief exposure periodArterial diseaseBalloon angioplastyPatency ratesVascular diseaseBalloon catheterCoated balloonMEDLINE searchStent failureActive drug
2014
Renal sympathetic denervation in the treatment of resistant hypertension.
Sánchez-Álvarez C, González-Vélez M, Stilp E, Ward C, Mena-Hurtado C. Renal sympathetic denervation in the treatment of resistant hypertension. The Yale Journal Of Biology And Medicine 2014, 87: 527-35. PMID: 25506285, PMCID: PMC4257026.Peer-Reviewed Original ResearchConceptsTreatment-resistant hypertensionRenal sympathetic denervationSympathetic denervationBlood pressureRenal arteryEfficacy of RSDSYMPLICITY HTN-3 studyDifferent antihypertensive medicationsSympathetic nerve hyperactivityMinor adverse eventsTarget blood pressureCommon femoral arteryMain renal arteryMajor health problemAntihypertensive medicationsRenal denervationRenal sympathectomySymplicity catheterArterial hypertensionResistant hypertensionAdverse eventsConsiderable morbidityEndovascular approachFemoral arteryConcomitant use